In this study, we sought to define the cellular and regional expression of the gene encoding for PAD2 (i.e. PADI2) in the CNS and evaluate whether anti-PAD2 antibodies were present in patients with MS and other neurologic diseases with known or suspected autoimmune etiology. This evidence concerns the gene PADI2 and myeloid sarcoma.